Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.

Zhang L, Wu H, Lu D, Li G, Sun C, Song H, Li J, Zhai T, Huang L, Hou C, Wang W, Zhou B, Chen S, Lu B, Zhang X.

Oncogene. 2013 Nov 14;32(46):5347-58. doi: 10.1038/onc.2012.600. Epub 2013 Jan 14.

2.

Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.

Chen C, Qu QX, Shen Y, Mu CY, Zhu YB, Zhang XG, Huang JA.

Cancer Lett. 2012 Apr 1;317(1):99-105. doi: 10.1016/j.canlet.2011.11.017. Epub 2011 Nov 20.

PMID:
22108530
3.

Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.

Arigami T, Uenosono Y, Ishigami S, Hagihara T, Haraguchi N, Natsugoe S.

World J Surg. 2011 Sep;35(9):2051-7. doi: 10.1007/s00268-011-1186-4.

PMID:
21748517
4.

B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.

Qian Y, Hong B, Shen L, Wu Z, Yao H, Zhang L.

Cell Tissue Res. 2013 Jul;353(1):139-51. doi: 10.1007/s00441-013-1640-8. Epub 2013 May 10.

PMID:
23660627
5.

Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.

Quandt D, Jasinski-Bergner S, Müller U, Schulze B, Seliger B.

J Transl Med. 2014 May 30;12:151. doi: 10.1186/1479-5876-12-151.

6.

Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines.

Park GB, Song H, Kim YS, Sung M, Ryu JW, Lee HK, Cho DH, Kim D, Lee WJ, Hur DY.

Immunology. 2009 Nov;128(3):360-8. doi: 10.1111/j.1365-2567.2009.03111.x.

7.

Functional interaction of the Ras effector RASSF5 with the tyrosine kinase Lck: critical role in nucleocytoplasmic transport and cell cycle regulation.

Kumari G, Singhal PK, Suryaraja R, Mahalingam S.

J Mol Biol. 2010 Mar 19;397(1):89-109. doi: 10.1016/j.jmb.2010.01.005. Epub 2010 Jan 11.

PMID:
20064523
8.

Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.

Leung J, Suh WK.

J Immunol. 2013 Jun 15;190(12):6651-61. doi: 10.4049/jimmunol.1201242. Epub 2013 May 17.

9.

Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis.

Chen L, Lu Y, Wang F, Zhou M, Chu Y, Ding W, Liu C, Xie J, Wu C, Jiang J.

Immunol Lett. 2013 Jul-Aug;154(1-2):25-30. doi: 10.1016/j.imlet.2013.07.009. Epub 2013 Aug 22.

PMID:
23973734
10.

B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.

Zhao LW, Li C, Zhang RL, Xue HG, Zhang FX, Zhang F, Gai XD.

Acta Histochem. 2014 Sep;116(7):1163-8. doi: 10.1016/j.acthis.2014.06.003. Epub 2014 Jul 19.

PMID:
25053455
11.

[Inhibition of PI3K/AKT signaling pathway promotes the nuclear translocation of B7-H4].

Song H, Xie W, Lian Q, Chen M, Xu R, Zeng S, Zhang L.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Nov;30(11):1121-4. Chinese.

PMID:
25374071
12.

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.

Krambeck AE, Thompson RH, Dong H, Lohse CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC, Kwon ED.

Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10391-6. Epub 2006 Jun 23.

13.

Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD8O) costimulation.

Wang YC, Zhu L, McHugh R, Graham SD Jr, Hillyer CD, Dillehay D, Sell KW, Selvaraj P.

J Immunother Emphasis Tumor Immunol. 1996 Jan;19(1):1-8.

PMID:
9147700
14.

Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines.

Sun SQ, Jiang CG, Lin Y, Jin YL, Huang PL.

J Int Med Res. 2012;40(2):497-506.

PMID:
22613410
15.

Expression of costimulatory molecule B7-H4 in human malignant tumors.

Zheng X, Li XD, Wu CP, Lu BF, Jiang JT.

Onkologie. 2012;35(11):700-5. doi: 10.1159/000343638. Epub 2012 Oct 22. Review.

PMID:
23147549
16.

B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.

Lee IF, Wang X, Hao J, Akhoundsadegh N, Chen L, Liu L, Langermann S, Ou D, Warnock GL.

Cell Immunol. 2013 Mar;282(1):1-8. doi: 10.1016/j.cellimm.2013.03.005. Epub 2013 Apr 4.

PMID:
23623902
17.

B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation.

Wang X, Hao J, Metzger DL, Ao Z, Chen L, Ou D, Verchere CB, Mui A, Warnock GL.

PLoS One. 2012;7(1):e28232. doi: 10.1371/journal.pone.0028232. Epub 2012 Jan 4.

18.

B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration.

Miyatake T, Tringler B, Liu W, Liu SH, Papkoff J, Enomoto T, Torkko KC, Dehn DL, Swisher A, Shroyer KR.

Gynecol Oncol. 2007 Jul;106(1):119-27. Epub 2007 May 16.

PMID:
17509674
19.
20.

B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.

Quandt D, Fiedler E, Boettcher D, Marsch WCh, Seliger B.

Clin Cancer Res. 2011 May 15;17(10):3100-11. doi: 10.1158/1078-0432.CCR-10-2268. Epub 2011 Mar 4.

Supplemental Content

Support Center